Antiproteinuric effect of olmesartan in patients with IgA nephropathy

IgA nephropathy is one of the most common primary glomerulonephritides, and the clinical course of almost 40% of the patients progresses to end-stage renal disease (ESRD) within 20 years. Angiotensin-converting enzyme (ACE) inhibitors and/ or angiotensin II receptor blockers (ARBs) induce a marked r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of nephrology 2009-03, Vol.22 (2), p.224-231
Hauptverfasser:	Tomino, Yasuhiko, Kawamura, Tetsuya, Kimura, Kenjiro, Endoh, Masayuki, Hosoya, Tatsuo, Horikoshi, Satoshi, Utsunomiya, Yasunori, Yasuda, Takashi, Toyoda, Masao, Tsuge, Toshinao, Kaneko, Kotaro
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Angiotensin II Type 1 Receptor Blockers - administration & dosage Angiotensin II Type 1 Receptor Blockers - therapeutic use Blood Pressure - drug effects Dose-Response Relationship, Drug Female Follow-Up Studies Glomerulonephritis, IGA - complications Glomerulonephritis, IGA - drug therapy Glomerulonephritis, IGA - urine Humans Imidazoles - administration & dosage Imidazoles - therapeutic use Male Middle Aged Proteinuria - drug therapy Proteinuria - etiology Proteinuria - urine Tetrazoles - administration & dosage Tetrazoles - therapeutic use Treatment Outcome Urinalysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!